Analyzing GoodRx (NASDAQ:GDRX) & Xylo Technologies (NASDAQ:XYLO)

GoodRx (NASDAQ:GDRX) and Xylo Technologies (NASDAQ:XYLO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation.

Institutional & Insider Ownership

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 0.3% of Xylo Technologies shares are owned by institutional investors. 4.2% of GoodRx shares are owned by company insiders. Comparatively, 2.2% of Xylo Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility & Risk

GoodRx has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Comparatively, Xylo Technologies has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for GoodRx and Xylo Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	0	3	6	1	2.80
Xylo Technologies	0	0	0	0	0.00

GoodRx currently has a consensus target price of $8.18, indicating a potential upside of 77.33%. Given GoodRx’s stronger consensus rating and higher possible upside, equities research analysts clearly believe GoodRx is more favorable than Xylo Technologies.

Profitability

This table compares GoodRx and Xylo Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GoodRx	-2.05%	5.35%	2.51%
Xylo Technologies	N/A	N/A	N/A

Earnings and Valuation

This table compares GoodRx and Xylo Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$792.32 million	2.22	-$8.87 million	$0.05	92.20
Xylo Technologies	$57.64 million	0.06	-$16.02 million	N/A	N/A

GoodRx has higher revenue and earnings than Xylo Technologies.

Summary

GoodRx beats Xylo Technologies on 12 of the 13 factors compared between the two stocks.

About GoodRx

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

About Xylo Technologies

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.